Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katherine Burdick, Ph.D.

Title
Institution
Department
Address
Profile Picture

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01MH102257 (BURDICK, KATHERINE ELIZABETH) Jul 23, 2014 - Mar 31, 2018
    NIH/NIMH
    1/2-Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
    Role: Principal Investigator
  2. I01CX000995 (BURDICK, KATHERINE ELIZABETH) Jan 1, 2014 - Dec 31, 2017
    VA
    Neurocognitive Heterogeneity in Patients with Psychosis _ A Dimensional Approach
    Role: Principal Investigator
  3. R34MH101267 (BURDICK, KATHERINE ELIZABETH) Aug 22, 2013 - Jun 30, 2016
    NIH/NIMH
    Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder with Modafinil
    Role: Principal Investigator
  4. R01MH100125 (BURDICK, KATHERINE ELIZABETH) Aug 5, 2013 - Apr 30, 2018
    NIH/NIMH
    Understanding the neurocognitive heterogeneity in bipolar disorder
    Role: Principal Investigator
  5. K23MH077807 (BURDICK, KATHERINE ELIZABETH) Jan 1, 2008 - May 30, 2013
    NIH/NIMH
    Neurocognition as an endophenotype in bipolar disorder
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Larsen EM, Ospina LH, Cuesta-Diaz A, Vian-Lains A, Nitzburg GC, Mulaimovic S, Latifoglu A, Clari R, Burdick KE. Effects of childhood trauma on adult moral decision-making: Clinical correlates and insights from bipolar disorder. J Affect Disord. 2019 Feb 01; 244:180-186. PMID: 30343121.
    View in: PubMed
  2. Stern ER, Shahab R, Grimaldi SJ, Leibu E, Murrough JW, Fleysher L, Parides MK, Coffey BJ, Burdick KE, Goodman WK. High-dose ondansetron reduces activation of interoceptive and sensorimotor brain regions. Neuropsychopharmacology. 2018 Aug 08. PMID: 30116006.
    View in: PubMed
  3. Lam M, Trampush JW, Yu J, Knowles E, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA, Glahn DC, Malhotra AK, Lencz T. Multi-Trait Analysis of GWAS and Biological Insights Into Cognition: A Response to Hill (2018). Twin Res Hum Genet. 2018 Oct; 21(5):394-397. PMID: 30001766.
    View in: PubMed
  4. Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, Nagel M, Awasthi S, Barr PB, Coleman JRI, Grasby KL, Hammerschlag AR, Kaminski JA, Karlsson R, Krapohl E, Lam M, Nygaard M, Reynolds CA, Trampush JW, Young H, Zabaneh D, Hägg S, Hansell NK, Karlsson IK, Linnarsson S, Montgomery GW, Muñoz-Manchado AB, Quinlan EB, Schumann G, Skene NG, Webb BT, White T, Arking DE, Avramopoulos D, Bilder RM, Bitsios P, Burdick KE, Cannon TD, Chiba-Falek O, Christoforou A, Cirulli ET, Congdon E, Corvin A, Davies G, Deary IJ, DeRosse P, Dickinson D, Djurovic S, Donohoe G, Conley ED, Eriksson JG, Espeseth T, Freimer NA, Giakoumaki S, Giegling I, Gill M, Glahn DC, Hariri AR, Hatzimanolis A, Keller MC, Knowles E, Koltai D, Konte B, Lahti J, Le Hellard S, Lencz T, Liewald DC, London E, Lundervold AJ, Malhotra AK, Melle I, Morris D, Need AC, Ollier W, Palotie A, Payton A, Pendleton N, Poldrack RA, Räikkönen K, Reinvang I, Roussos P, Rujescu D, Sabb FW, Scult MA, Smeland OB, Smyrnis N, Starr JM, Steen VM, Stefanis NC, Straub RE, Sundet K, Tiemeier H, Voineskos AN, Weinberger DR, Widen E, Yu J, Abecasis G, Andreassen OA, Breen G, Christiansen L, Debrabant B, Dick DM, Heinz A, Hjerling-Leffler J, Ikram MA, Kendler KS, Martin NG, Medland SE, Pedersen NL, Plomin R, Polderman TJC, Ripke S, van der Sluis S, Sullivan PF, Vrieze SI, Wright MJ, Posthuma D. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018 Jul; 50(7):912-919. PMID: 29942086.
    View in: PubMed
  5. Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, Hagenaars SP, Ritchie SJ, Marioni RE, Fawns-Ritchie C, Liewald DCM, Okely JA, Ahola-Olli AV, Barnes CLK, Bertram L, Bis JC, Burdick KE, Christoforou A, DeRosse P, Djurovic S, Espeseth T, Giakoumaki S, Giddaluru S, Gustavson DE, Hayward C, Hofer E, Ikram MA, Karlsson R, Knowles E, Lahti J, Leber M, Li S, Mather KA, Melle I, Morris D, Oldmeadow C, Palviainen T, Payton A, Pazoki R, Petrovic K, Reynolds CA, Sargurupremraj M, Scholz M, Smith JA, Smith AV, Terzikhan N, Thalamuthu A, Trompet S, van der Lee SJ, Ware EB, Windham BG, Wright MJ, Yang J, Yu J, Ames D, Amin N, Amouyel P, Andreassen OA, Armstrong NJ, Assareh AA, Attia JR, Attix D, Avramopoulos D, Bennett DA, Böhmer AC, Boyle PA, Brodaty H, Campbell H, Cannon TD, Cirulli ET, Congdon E, Conley ED, Corley J, Cox SR, Dale AM, Dehghan A, Dick D, Dickinson D, Eriksson JG, Evangelou E, Faul JD, Ford I, Freimer NA, Gao H, Giegling I, Gillespie NA, Gordon SD, Gottesman RF, Griswold ME, Gudnason V, Harris TB, Hartmann AM, Hatzimanolis A, Heiss G, Holliday EG, Joshi PK, Kähönen M, Kardia SLR, Karlsson I, Kleineidam L, Knopman DS, Kochan NA, Konte B, Kwok JB, Le Hellard S, Lee T, Lehtimäki T, Li SC, Liu T, Koini M, London E, Longstreth WT, Lopez OL, Loukola A, Luck T, Lundervold AJ, Lundquist A, Lyytikäinen LP, Martin NG, Montgomery GW, Murray AD, Need AC, Noordam R, Nyberg L, Ollier W, Papenberg G, Pattie A, Polasek O, Poldrack RA, Psaty BM, Reppermund S, Riedel-Heller SG, Rose RJ, Rotter JI, Roussos P, Rovio SP, Saba Y, Sabb FW, Sachdev PS, Satizabal CL, Schmid M, Scott RJ, Scult MA, Simino J, Slagboom PE, Smyrnis N, Soumaré A, Stefanis NC, Stott DJ, Straub RE, Sundet K, Taylor AM, Taylor KD, Tzoulaki I, Tzourio C, Uitterlinden A, Vitart V, Voineskos AN, Kaprio J, Wagner M, Wagner H, Weinhold L, Wen KH, Widen E, Yang Q, Zhao W, Adams HHH, Arking DE, Bilder RM, Bitsios P, Boerwinkle E, Chiba-Falek O, Corvin A, De Jager PL, Debette S, Donohoe G, Elliott P, Fitzpatrick AL, Gill M, Glahn DC, Hägg S, Hansell NK, Hariri AR, Ikram MK, Jukema JW, Vuoksimaa E, Keller MC, Kremen WS, Launer L, Lindenberger U, Palotie A, Pedersen NL, Pendleton N, Porteous DJ, Räikkönen K, Raitakari OT, Ramirez A, Reinvang I, Rudan I, Schmidt R, Schmidt H, Schofield PW, Schofield PR, Starr JM, Steen VM, Trollor JN, Turner ST, Van Duijn CM, Villringer A, Weinberger DR, Weir DR, Wilson JF, Malhotra A, McIntosh AM, Gale CR, Seshadri S, Mosley TH, Bressler J, Lencz T, Deary IJ. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2018 05 29; 9(1):2098. PMID: 29844566.
    View in: PubMed
  6. Ospina LH, Nitzburg GC, Shanahan M, Perez-Rodriguez MM, Larsen E, Latifoglu A, Burdick KE. Social cognition moderates the relationship between neurocognition and community functioning in bipolar disorder. J Affect Disord. 2018 08 01; 235:7-14. PMID: 29631204.
    View in: PubMed
  7. Lam M, Trampush JW, Yu J, Knowles E, Davies G, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK, Lencz T. Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets. Cell Rep. 2017 Nov 28; 21(9):2597-2613. PMID: 29186694.
    View in: PubMed
  8. Trampush JW, Yang MLZ, Yu J, Knowles E, Davies G, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK, Lencz T. GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium. Mol Psychiatry. 2017 11; 22(11):1651-1652. PMID: 29068436.
    View in: PubMed
  9. Stern ER, Grimaldi SJ, Muratore A, Murrough J, Leibu E, Fleysher L, Goodman WK, Burdick KE. Neural correlates of interoception: Effects of interoceptive focus and relationship to dimensional measures of body awareness. Hum Brain Mapp. 2017 12; 38(12):6068-6082. PMID: 28901713.
    View in: PubMed
  10. Mahon PB, Hildebrandt TB, Burdick KE. New Genetic Discoveries in Anorexia Nervosa: Implications for the Field. Am J Psychiatry. 2017 09 01; 174(9):821-822. PMID: 28859512.
    View in: PubMed
  11. Russo M, Van Rheenen TE, Shanahan M, Mahon K, Perez-Rodriguez MM, Cuesta-Diaz A, Larsen E, Malhotra AK, Burdick KE. Neurocognitive subtypes in patients with bipolar disorder and their unaffected siblings. Psychol Med. 2017 Dec; 47(16):2892-2905. PMID: 28587689.
    View in: PubMed
  12. Miskowiak KW, Kjaerstad HL, Støttrup MM, Svendsen AM, Demant KM, Hoeffding LK, Werge TM, Burdick KE, Domschke K, Carvalho AF, Vieta E, Vinberg M, Kessing LV, Siebner HR, Macoveanu J. The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder. Bipolar Disord. 2017 05; 19(3):214-224. PMID: 28544426.
    View in: PubMed
  13. Nitzburg GC, Cuesta-Diaz A, Ospina LH, Russo M, Shanahan M, Perez-Rodriguez M, Larsen E, Mulaimovic S, Burdick KE. Organizational Learning Strategies and Verbal Memory Deficits in Bipolar Disorder. J Int Neuropsychol Soc. 2017 04; 23(4):358-366. PMID: 28382899.
    View in: PubMed
  14. Van Rheenen TE, Lewandowski KE, Tan EJ, Ospina LH, Ongur D, Neill E, Gurvich C, Pantelis C, Malhotra AK, Rossell SL, Burdick KE. Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum. Psychol Med. 2017 Jul; 47(10):1848-1864. PMID: 28241891.
    View in: PubMed
  15. Trampush JW, Yang ML, Yu J, Knowles E, Davies G, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon TD, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK, Lencz T. GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium. Mol Psychiatry. 2017 03; 22(3):336-345. PMID: 28093568.
    View in: PubMed
  16. Hauser M, Zhang JP, Sheridan EM, Burdick KE, Mogil R, Kane JM, Auther A, Carrión RE, Cornblatt BA, Correll CU. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis. J Clin Psychiatry. 2017 01; 78(1):e28-e40. PMID: 28129494.
    View in: PubMed
  17. Ospina LH, Russo M, Nitzburg GM, Cuesta-Diaz A, Shanahan M, Perez-Rodriguez MM, Mcgrath M, Levine H, Mulaimovic S, Burdick KE. The effects of cigarette smoking behavior and psychosis history on general and social cognition in bipolar disorder. Bipolar Disord. 2016 09; 18(6):528-538. PMID: 27650399.
    View in: PubMed
  18. Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, Bhattacharjee A, Brennand KJ, Burdick KE, Calabrese JR, Calkin CV, Claasen A, Coryell WH, Craig D, DeModena A, Frye M, Gage FH, Gao K, Garnham J, Gershon E, Jakobsen P, Leckband SG, McCarthy MJ, McInnis MG, Maihofer AX, Mertens J, Morken G, Nievergelt CM, Nurnberger J, Pham S, Schoeyen H, Shekhtman T, Shilling PD, Szelinger S, Tarwater B, Yao J, Zandi PP, Kelsoe JR. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. BMC Psychiatry. 2016 May 05; 16:129. PMID: 27150464; PMCID: PMC4857276.
  19. Nitzburg GC, Russo M, Cuesta-Diaz A, Ospina L, Shanahan M, Perez-Rodriguez M, McGrath M, Burdick KE. Coping strategies and real-world functioning in bipolar disorder. J Affect Disord. 2016 07 01; 198:185-8. PMID: 27017375.
    View in: PubMed
  20. Trampush JW, Lencz T, DeRosse P, John M, Gallego JA, Petrides G, Hassoun Y, Zhang JP, Addington J, Kellner CH, Tohen M, Burdick KE, Goldberg TE, Kane JM, Robinson DG, Malhotra AK. Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. Schizophr Bull. 2015 Nov; 41(6):1237-47. PMID: 26409223; PMCID: PMC4601719 [Available on 11/01/16].
  21. Howrigan DP, Simonson MA, Davies G, Harris SE, Tenesa A, Starr JM, Liewald DC, Deary IJ, McRae A, Wright MJ, Montgomery GW, Hansell N, Martin NG, Payton A, Horan M, Ollier WE, Abdellaoui A, Boomsma DI, DeRosse P, Knowles EE, Glahn DC, Djurovic S, Melle I, Andreassen OA, Christoforou A, Steen VM, Hellard SL, Sundet K, Reinvang I, Espeseth T, Lundervold AJ, Giegling I, Konte B, Hartmann AM, Rujescu D, Roussos P, Giakoumaki S, Burdick KE, Bitsios P, Donohoe G, Corley RP, Visscher PM, Pendleton N, Malhotra AK, Neale BM, Lencz T, Keller MC. Genome-wide autozygosity is associated with lower general cognitive ability. Mol Psychiatry. 2016 06; 21(6):837-43. PMID: 26390830.
    View in: PubMed
  22. Russo M, Mahon K, Shanahan M, Ramjas E, Solon C, Purcell SM, Burdick KE. The relationship between sleep quality and neurocognition in bipolar disorder. J Affect Disord. 2015 Nov 15; 187:156-62. PMID: 26339925; PMCID: PMC4598049 [Available on 11/15/16].
  23. Trampush JW, Lencz T, Knowles E, Davies G, Guha S, Pe'er I, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse P, Lundervold A, Steen VM, John M, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Scult M, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri A, Weinberger DR, Pendleton N, Iwata N, Darvasi A, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK. Independent evidence for an association between general cognitive ability and a genetic locus for educational attainment. Am J Med Genet B Neuropsychiatr Genet. 2015 Jul; 168B(5):363-73. PMID: 25951819.
    View in: PubMed
  24. Murrough JW, Burdick KE, Levitch CF, Perez AM, Brallier JW, Chang LC, Foulkes A, Charney DS, Mathew SJ, Iosifescu DV. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial. Neuropsychopharmacology. 2015 Mar 13; 40(5):1084-90. PMID: 25374095; PMCID: PMC4367458.
  25. Nitzburg GC, Burdick KE, Malhotra AK, DeRosse P. Social cognition in patients with schizophrenia spectrum and bipolar disorders with and without psychotic features. Schizophr Res Cogn. 2015 Mar; 2(1):2-7. PMID: 29379754.
    View in: PubMed
  26. Toteja N, Guvenek-Cokol P, Ikuta T, Kafantaris V, Peters BD, Burdick KE, John M, Malhotra AK, Szeszko PR. Age-associated alterations in corpus callosum white matter integrity in bipolar disorder assessed using probabilistic tractography. Bipolar Disord. 2015 Jun; 17(4):381-91. PMID: 25532972; PMCID: PMC4458202.
  27. Russo M, Mahon K, Burdick KE. Measuring cognitive function in MDD: emerging assessment tools. Depress Anxiety. 2015 Apr; 32(4):262-9. PMID: 25421437; PMCID: PMC4407945.
  28. Russo M, Mahon K, Shanahan M, Ramjas E, Solon C, Braga RJ, Burdick KE. Affective temperaments and neurocognitive functioning in bipolar disorder. J Affect Disord. 2014 Dec; 169:51-6. PMID: 25151191; PMCID: PMC4172290.
  29. Mercedes Perez-Rodriguez M, Mahon K, Russo M, Ungar AK, Burdick KE. Oxytocin and social cognition in affective and psychotic disorders. Eur Neuropsychopharmacol. 2015 Feb; 25(2):265-82. PMID: 25153535; PMCID: PMC4443696.
  30. Burdick KE, Russo M, Frangou S, Mahon K, Braga RJ, Shanahan M, Malhotra AK. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol Med. 2014 Oct; 44(14):3083-96. PMID: 25065409; PMCID: PMC4797987.
  31. Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse P, Lundervold A, Steen VM, John M, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Donohoe G, Morris D, Corvin A, Gill M, Pendleton N, Iwata N, Darvasi A, Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). Mol Psychiatry. 2014 Feb; 19(2):168-74. PMID: 24342994; PMCID: PMC3968799.
  32. Nitzburg GC, Derosse P, Burdick KE, Peters BD, Gopin CB, Malhotra AK. MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults. Schizophr Res. 2014 Jan; 152(1):223-8. PMID: 24321710; PMCID: PMC3918455.
  33. Dima D, Jogia J, Collier D, Vassos E, Burdick KE, Frangou S. Independent modulation of engagement and connectivity of the facial network during affect processing by CACNA1C and ANK3 risk genes for bipolar disorder. JAMA Psychiatry. 2013 Dec; 70(12):1303-11. PMID: 24108394.
    View in: PubMed
  34. Powers RL, Russo M, Mahon K, Brand J, Braga RJ, Malhotra AK, Burdick KE. Impulsivity in bipolar disorder: relationships with neurocognitive dysfunction and substance use history. Bipolar Disord. 2013 Dec; 15(8):876-84. PMID: 24028391; PMCID: PMC3855192.
  35. Murrough JW, Wan LB, Iacoviello B, Collins KA, Solon C, Glicksberg B, Perez AM, Mathew SJ, Charney DS, Iosifescu DV, Burdick KE. Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology (Berl). 2013 Sep 11. PMID: 24022236.
    View in: PubMed
  36. Mahon K, Perez-Rodriguez MM, Gunawardane N, Burdick KE. Dimensional endophenotypes in bipolar disorder: affective dysregulation and psychosis proneness. J Affect Disord. 2013 Nov; 151(2):695-701. PMID: 23993441; PMCID: PMC3844544.
  37. Russo M, Proujansky R, Gilbert A, Braga RJ, Burdick KE. Initial evidence for sex-specific effects of early emotional abuse on affective processing in bipolar disorder. Eur Psychiatry. 2014 Jan; 29(1):52-7. PMID: 23928266.
    View in: PubMed
  38. Burdick KE, Braga RJ, Gopin CB, Malhotra AK. Dopaminergic influences on emotional decision making in euthymic bipolar patients. Neuropsychopharmacology. 2014 Jan; 39(2):274-82. PMID: 23884342; PMCID: PMC3870768.
  39. Argyelan M, Ikuta T, DeRosse P, Braga RJ, Burdick KE, John M, Kingsley PB, Malhotra AK, Szeszko PR. Resting-state fMRI connectivity impairment in schizophrenia and bipolar disorder. Schizophr Bull. 2014 Jan; 40(1):100-10. PMID: 23851068; PMCID: PMC3885301.
  40. Peters BD, Ikuta T, DeRosse P, John M, Burdick KE, Gruner P, Prendergast DM, Szeszko PR, Malhotra AK. Age-related differences in white matter tract microstructure are associated with cognitive performance from childhood to adulthood. Biol Psychiatry. 2014 Feb 01; 75(3):248-56. PMID: 23830668; PMCID: PMC4412928.
  41. Anderson D, Ardekani BA, Burdick KE, Robinson DG, John M, Malhotra AK, Szeszko PR. Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder. Bipolar Disord. 2013 Sep; 15(6):680-93. PMID: 23796123; PMCID: PMC3762889.
  42. DeRosse P, Burdick KE, Lencz T, Siris SG, Malhotra AK. Empirical support for DSM-IV schizoaffective disorder: clinical and cognitive validators from a large patient sample. PLoS One. 2013; 8(5):e63734. PMID: 23737946; PMCID: PMC3667842.
  43. Donohoe G, Deary IJ, Glahn DC, Malhotra AK, Burdick KE. Neurocognitive phenomics: examining the genetic basis of cognitive abilities. Psychol Med. 2013 Oct; 43(10):2027-36. PMID: 23194477.
    View in: PubMed
  44. Mahon K, Burdick KE, Ikuta T, Braga RJ, Gruner P, Malhotra AK, Szeszko PR. Abnormal temporal lobe white matter as a biomarker for genetic risk of bipolar disorder. Biol Psychiatry. 2013 Jan 15; 73(2):177-82. PMID: 23036958; PMCID: PMC3760506.
  45. Braga RJ, Burdick KE, Derosse P, Malhotra AK. Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Res. 2012 Dec 30; 200(2-3):242-5. PMID: 22818174; PMCID: PMC4408776.
  46. Brand JG, Goldberg TE, Gunawardane N, Gopin CB, Powers RL, Malhotra AK, Burdick KE. Emotional bias in unaffected siblings of patients with bipolar I disorder. J Affect Disord. 2012 Feb; 136(3):1053-8. PMID: 22209123; PMCID: PMC3380628.
  47. Malhotra D, McCarthy S, Michaelson JJ, Vacic V, Burdick KE, Yoon S, Cichon S, Corvin A, Gary S, Gershon ES, Gill M, Karayiorgou M, Kelsoe JR, Krastoshevsky O, Krause V, Leibenluft E, Levy DL, Makarov V, Bhandari A, Malhotra AK, McMahon FJ, Nöthen MM, Potash JB, Rietschel M, Schulze TG, Sebat J. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron. 2011 Dec 22; 72(6):951-63. PMID: 22196331.
    View in: PubMed
  48. Burdick KE, Braga RJ, Nnadi CU, Shaya Y, Stearns WH, Malhotra AK. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction. J Clin Psychiatry. 2012 Jan; 73(1):103-12. PMID: 22152405; PMCID: PMC4457389.
  49. Kang E, Burdick KE, Kim JY, Duan X, Guo JU, Sailor KA, Jung DE, Ganesan S, Choi S, Pradhan D, Lu B, Avramopoulos D, Christian K, Malhotra AK, Song H, Ming GL. Interaction between FEZ1 and DISC1 in regulation of neuronal development and risk for schizophrenia. Neuron. 2011 Nov 17; 72(4):559-71. PMID: 22099459; PMCID: PMC3222865.
  50. Gilbert AM, Garno JL, Braga RJ, Shaya Y, Goldberg TE, Malhotra AK, Burdick KE. Clinical and cognitive correlates of suicide attempts in bipolar disorder: is suicide predictable? J Clin Psychiatry. 2011 Aug; 72(8):1027-33. PMID: 21813075; PMCID: PMC4035109.
  51. Burdick KE, Gopin CB, Malhotra AK. Pharmacogenetic approaches to cognitive enhancement in schizophrenia. Harv Rev Psychiatry. 2011 May-Jun; 19(3):102-8. PMID: 21631157.
    View in: PubMed
  52. Pinsonneault JK, Han DD, Burdick KE, Kataki M, Bertolino A, Malhotra AK, Gu HH, Sadee W. Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Neuropsychopharmacology. 2011 Jul; 36(8):1644-55. PMID: 21525861; PMCID: PMC3138671.
  53. Burdick KE, Goldberg TE, Cornblatt BA, Keefe RS, Gopin CB, Derosse P, Braga RJ, Malhotra AK. The MATRICS consensus cognitive battery in patients with bipolar I disorder. Neuropsychopharmacology. 2011 Jul; 36(8):1587-92. PMID: 21451499; PMCID: PMC3138672.
  54. Gopin CB, Burdick KE, Derosse P, Goldberg TE, Malhotra AK. Emotional modulation of response inhibition in stable patients with bipolar I disorder: a comparison with healthy and schizophrenia subjects. Bipolar Disord. 2011 Mar; 13(2):164-72. PMID: 21443570; PMCID: PMC3066455.
  55. Glahn DC, Burdick KE. Clinical endophenotypes for bipolar disorder. Curr Top Behav Neurosci. 2011; 5:51-67. PMID: 25236549.
    View in: PubMed
  56. Zhang JP, Burdick KE, Lencz T, Malhotra AK. Meta-analysis of genetic variation in DTNBP1 and general cognitive ability. Biol Psychiatry. 2010 Dec 15; 68(12):1126-33. PMID: 21130223; PMCID: PMC3026311.
  57. Burdick KE, Goldberg JF, Harrow M. Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up. Acta Psychiatr Scand. 2010 Dec; 122(6):499-506. PMID: 20637012; PMCID: PMC2980854.
  58. Shamsi S, Lau A, Lencz T, Burdick KE, DeRosse P, Brenner R, Lindenmayer JP, Malhotra AK. Cognitive and symptomatic predictors of functional disability in schizophrenia. Schizophr Res. 2011 Mar; 126(1-3):257-64. PMID: 20828991; PMCID: PMC3050077.
  59. Lencz T, Szeszko PR, DeRosse P, Burdick KE, Bromet EJ, Bilder RM, Malhotra AK. A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes. Neuropsychopharmacology. 2010 Oct; 35(11):2284-91. PMID: 20664580; PMCID: PMC2939918.
  60. Harvey PD, Wingo AP, Burdick KE, Baldessarini RJ. Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord. 2010 Jun; 12(4):364-75. PMID: 20636633.
    View in: PubMed
  61. Yatham LN, Torres IJ, Malhi GS, Frangou S, Glahn DC, Bearden CE, Burdick KE, Martínez-Arán A, Dittmann S, Goldberg JF, Ozerdem A, Aydemir O, Chengappa KN. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord. 2010 Jun; 12(4):351-63. PMID: 20636632.
    View in: PubMed
  62. DeRosse P, Kaplan A, Burdick KE, Lencz T, Malhotra AK. Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophr Res. 2010 Jul; 120(1-3):95-100. PMID: 20483565; PMCID: PMC2902262.
  63. Burdick KE, DeRosse P, Kane JM, Lencz T, Malhotra AK. Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability. Am J Psychiatry. 2010 Apr; 167(4):436-43. PMID: 20080979; PMCID: PMC2848873.
  64. Mahon K, Burdick KE, Szeszko PR. A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev. 2010 Mar; 34(4):533-54. PMID: 19896972; PMCID: PMC2847441.
  65. Narr KL, Szeszko PR, Lencz T, Woods RP, Hamilton LS, Phillips O, Robinson D, Burdick KE, DeRosse P, Kucherlapati R, Thompson PM, Toga AW, Malhotra AK, Bilder RM. DTNBP1 is associated with imaging phenotypes in schizophrenia. Hum Brain Mapp. 2009 Nov; 30(11):3783-94. PMID: 19449336; PMCID: PMC3176807.
  66. Lencz T, Lipsky RH, DeRosse P, Burdick KE, Kane JM, Malhotra AK. Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. Br J Psychiatry. 2009 Apr; 194(4):313-8. PMID: 19336781.
    View in: PubMed
  67. Coscia DM, Narr KL, Robinson DG, Hamilton LS, Sevy S, Burdick KE, Gunduz-Bruce H, McCormack J, Bilder RM, Szeszko PR. Volumetric and shape analysis of the thalamus in first-episode schizophrenia. Hum Brain Mapp. 2009 Apr; 30(4):1236-45. PMID: 18570200.
    View in: PubMed
  68. Burdick KE, Gunawardane N, Goldberg JF, Halperin JM, Garno JL, Malhotra AK. Attention and psychomotor functioning in bipolar depression. Psychiatry Res. 2009 Apr 30; 166(2-3):192-200. PMID: 19272656.
    View in: PubMed
  69. Mahon K, Wu J, Malhotra AK, Burdick KE, DeRosse P, Ardekani BA, Szeszko PR. A voxel-based diffusion tensor imaging study of white matter in bipolar disorder. Neuropsychopharmacology. 2009 May; 34(6):1590-600. PMID: 19145224; PMCID: PMC2811531.
  70. Burdick KE, Gunawardane N, Woodberry K, Malhotra AK. The role of general intelligence as an intermediate phenotype for neuropsychiatric disorders. Cogn Neuropsychiatry. 2009; 14(4-5):299-311. PMID: 19634032; PMCID: PMC2727853.
  71. Goldberg TE, Burdick KE, McCormack J, Napolitano B, Patel RC, Sevy SM, Goldman R, Lencz T, Malhotra AK, Kane JM, Robinson DG. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia. Schizophr Res. 2009 Feb; 107(2-3):262-6. PMID: 19042105; PMCID: PMC2667951.
  72. Christian CJ, Lencz T, Robinson DG, Burdick KE, Ashtari M, Malhotra AK, Betensky JD, Szeszko PR. Gray matter structural alterations in obsessive-compulsive disorder: relationship to neuropsychological functions. Psychiatry Res. 2008 Nov 30; 164(2):123-31. PMID: 18938065; PMCID: PMC2654218.
  73. DeRosse P, Lencz T, Burdick KE, Siris SG, Kane JM, Malhotra AK. The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia. Schizophr Bull. 2008 Nov; 34(6):1047-53. PMID: 18628273; PMCID: PMC2632513.
  74. Burdick KE, Robinson DG, Malhotra AK, Szeszko PR. Neurocognitive profile analysis in obsessive-compulsive disorder. J Int Neuropsychol Soc. 2008 Jul; 14(4):640-5. PMID: 18577293.
    View in: PubMed
  75. Opgen-Rhein C, Lencz T, Burdick KE, Neuhaus AH, DeRosse P, Goldberg TE, Malhotra AK. Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance. Schizophr Res. 2008 Aug; 103(1-3):169-77. PMID: 18541412; PMCID: PMC2605318.
  76. Burdick KE, Kamiya A, Hodgkinson CA, Lencz T, DeRosse P, Ishizuka K, Elashvili S, Arai H, Goldman D, Sawa A, Malhotra AK. Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding. Hum Mol Genet. 2008 Aug 15; 17(16):2462-73. PMID: 18469341.
    View in: PubMed
  77. Lencz T, Lambert C, DeRosse P, Burdick KE, Morgan TV, Kane JM, Kucherlapati R, Malhotra AK. Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. Proc Natl Acad Sci U S A. 2007 Dec 11; 104(50):19942-7. PMID: 18077426; PMCID: PMC2148402.
  78. Szeszko PR, Hodgkinson CA, Robinson DG, Derosse P, Bilder RM, Lencz T, Burdick KE, Napolitano B, Betensky JD, Kane JM, Goldman D, Malhotra AK. DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol Psychol. 2008 Sep; 79(1):103-10. PMID: 18078707; PMCID: PMC2623247.
  79. Goldberg TE, Goldman RS, Burdick KE, Malhotra AK, Lencz T, Patel RC, Woerner MG, Schooler NR, Kane JM, Robinson DG. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect? Arch Gen Psychiatry. 2007 Oct; 64(10):1115-22. PMID: 17909123.
    View in: PubMed
  80. Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, Malhotra AK. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord. 2007 Jun; 9(4):370-6. PMID: 17547583.
    View in: PubMed
  81. Sevy S, Burdick KE, Visweswaraiah H, Abdelmessih S, Lukin M, Yechiam E, Bechara A. Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders. Schizophr Res. 2007 May; 92(1-3):74-84. PMID: 17379482; PMCID: PMC2039912.
  82. Burdick KE, Braga RJ, Goldberg JF, Malhotra AK. Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy. CNS Drugs. 2007; 21(12):971-81. PMID: 18020478.
    View in: PubMed
  83. Burdick KE, Goldberg TE, Funke B, Bates JA, Lencz T, Kucherlapati R, Malhotra AK. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):169-72. PMID: 17074466; PMCID: PMC1828039.
  84. DeRosse P, Hodgkinson CA, Lencz T, Burdick KE, Kane JM, Goldman D, Malhotra AK. Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biol Psychiatry. 2007 May 15; 61(10):1208-10. PMID: 17054920.
    View in: PubMed
  85. Sevy S, Hassoun Y, Bechara A, Yechiam E, Napolitano B, Burdick K, Delman H, Malhotra A. Emotion-based decision-making in healthy subjects: short-term effects of reducing dopamine levels. Psychopharmacology (Berl). 2006 Oct; 188(2):228-35. PMID: 16915385; PMCID: PMC2072533.
  86. DeRosse P, Funke B, Burdick KE, Lencz T, Goldberg TE, Kane JM, Kucherlapati R, Malhotra AK. COMT genotype and manic symptoms in schizophrenia. Schizophr Res. 2006 Oct; 87(1-3):28-31. PMID: 16828262.
    View in: PubMed
  87. Malhotra AK, Burdick KE, Razi K, Bates JA, Sanders M, Kane JM. Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity? Schizophr Res. 2006 Oct; 87(1-3):181-4. PMID: 16820282.
    View in: PubMed
  88. Kester HM, Sevy S, Yechiam E, Burdick KE, Cervellione KL, Kumra S. Decision-making impairments in adolescents with early-onset schizophrenia. Schizophr Res. 2006 Jul; 85(1-3):113-23. PMID: 16733084.
    View in: PubMed
  89. Roofeh D, Cottone J, Burdick KE, Lencz T, Gyato K, Cervellione KL, Napolitano B, Kester H, Anderson B, Kumra S. Deficits in memory strategy use are related to verbal memory impairments in adolescents with schizophrenia-spectrum disorders. Schizophr Res. 2006 Jul; 85(1-3):201-12. PMID: 16690255.
    View in: PubMed
  90. Burdick KE, Goldberg JF, Harrow M, Faull RN, Malhotra AK. Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. J Nerv Ment Dis. 2006 Apr; 194(4):255-60. PMID: 16614546.
    View in: PubMed
  91. DeRosse P, Funke B, Burdick KE, Lencz T, Ekholm JM, Kane JM, Kucherlapati R, Malhotra AK. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry. 2006 Mar; 163(3):532-4. PMID: 16513878.
    View in: PubMed
  92. Burdick KE, Lencz T, Funke B, Finn CT, Szeszko PR, Kane JM, Kucherlapati R, Malhotra AK. Genetic variation in DTNBP1 influences general cognitive ability. Hum Mol Genet. 2006 May 15; 15(10):1563-8. PMID: 16415041.
    View in: PubMed
  93. Thaden E, Rhinewine JP, Lencz T, Kester H, Cervellione KL, Henderson I, Roofeh D, Burdick KE, Napolitano B, Cornblatt BA, Kumra S. Early-onset schizophrenia is associated with impaired adolescent development of attentional capacity using the identical pairs continuous performance test. Schizophr Res. 2006 Jan 31; 81(2-3):157-66. PMID: 16309895.
    View in: PubMed
  94. Vega U, Silberman C, Laks J, Braga RJ, Burdick KE. Association of education and cognitive status in Brazilian elderly institutionalized patients with schizophrenia. Schizophr Res. 2005 Oct 01; 78(1):107-9. PMID: 15975767.
    View in: PubMed
  95. Burdick KE, Hodgkinson CA, Szeszko PR, Lencz T, Ekholm JM, Kane JM, Goldman D, Malhotra AK. DISC1 and neurocognitive function in schizophrenia. Neuroreport. 2005 Aug 22; 16(12):1399-402. PMID: 16056147.
    View in: PubMed
  96. Rhinewine JP, Lencz T, Thaden EP, Cervellione KL, Burdick KE, Henderson I, Bhaskar S, Keehlisen L, Kane J, Kohn N, Fisch GS, Bilder RM, Kumra S. Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates. Biol Psychiatry. 2005 Nov 01; 58(9):705-12. PMID: 16023084.
    View in: PubMed
  97. Goldberg JF, Burdick KE, Endick CJ. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry. 2004 Mar; 161(3):564-6. PMID: 14992985.
    View in: PubMed
  98. Goldberg JF, Burdick KE. Levetiracetam for acute mania. Am J Psychiatry. 2002 Jan; 159(1):148. PMID: 11772709.
    View in: PubMed
  99. Goldberg JF, Burdick KE. Cognitive side effects of anticonvulsants. J Clin Psychiatry. 2001; 62 Suppl 14:27-33. PMID: 11469672.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Burdick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (284)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.